Hyperfine, Inc.HYPREarnings & Financial Report
Hyperfine, Inc. develops and commercializes innovative portable low-field magnetic resonance imaging (MRI) systems for medical diagnostic use. Its solutions deliver accessible, cost-effective imaging for healthcare providers across acute care, rural clinics, pediatric care, and other underserved clinical settings worldwide.
Revenue
$3.6M
Gross Profit
$1.8M
Operating Profit
$-10.8M
Net Profit
$-10.2M
Gross Margin
49.7%
Operating Margin
-298.7%
Net Margin
-279.7%
YoY Growth
7.4%
EPS
$-0.14
Hyperfine, Inc. Q2 FY2024 Financial Summary
Hyperfine, Inc. reported revenue of $3.6M (up 7.4% YoY) for Q2 FY2024, with a net profit of $-10.2M (up 4.5% YoY) (-279.7% margin). Cost of goods sold was $1.8M, operating expenses totaled $12.6M.
Key Financial Metrics
| Total Revenue | $3.6M |
|---|---|
| Net Profit | $-10.2M |
| Gross Margin | 49.7% |
| Operating Margin | -298.7% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
Hyperfine, Inc. Q2 FY2024 revenue of $3.6M breaks down across 2 segments, led by Products at $3.0M (81.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $3.0M | 81.8% |
| Other | $661.0K | 18.2% |
Hyperfine, Inc. Revenue by Segment — Quarterly Trend
Hyperfine, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $4.9M | $2.9M | $2.1M | $1.5M |
| Other | $436.0K | $546.0K | $568.0K | $615.0K |
Hyperfine, Inc. Annual Revenue by Year
Hyperfine, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $13.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $13.6M |
| 2024 | $12.9M |
| 2023 | $11.0M |
| 2022 | $6.8M |
Hyperfine, Inc. Quarterly Revenue & Net Profit History
Hyperfine, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $5.3M | +128.0% | $-5.9M | -111.7% |
| Q3 FY2025 | $3.4M | -5.7% | $-11.0M | -320.6% |
| Q2 FY2025 | $2.7M | -25.8% | $-9.2M | -342.2% |
| Q1 FY2025 | $2.1M | -35.1% | $-9.4M | -440.7% |
| Q4 FY2024 | $2.3M | -13.6% | $-10.4M | -447.7% |
| Q3 FY2024 | $3.6M | +56.4% | $-10.3M | -283.4% |
| Q2 FY2024 | $3.6M | +7.4% | $-10.2M | -279.7% |
| Q1 FY2024 | $3.3M | +25.0% | $-9.8M | -298.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3M | $3.6M | $3.6M | $2.3M | $2.1M | $2.7M | $3.4M | $5.3M |
| YoY Growth | 25.0% | 7.4% | 56.4% | -13.6% | -35.1% | -25.8% | -5.7% | 128.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $85.4M | $76.6M | $69.4M | $58.9M | $53.4M | $45.2M | $41.5M | $55.3M |
| Liabilities | $9.8M | $9.8M | $11.1M | $9.9M | $10.3M | $10.1M | $14.6M | $14.3M |
| Equity | $75.6M | $66.8M | $58.3M | $49.0M | $43.1M | $35.1M | $26.9M | $41.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-12.5M | $-9.4M | $-8.5M | $-8.4M | $-9.2M | $-7.9M | $-5.6M | $-5.2M |